MicroRNA Cancer qpcr Array

Similar documents
Expression level of microrna-195 in the serum of patients with gastric cancer and its relationship with the clinicopathological staging of the cancer

Benchmarking the Multiplex Circulating and Cellular mirna Assays using Abcam s Firefly particle technology

MicroRNA expression profiles in human cancer cells after ionizing radiation

Original Article Increased expression of microrna-196a predicts poor prognosis in human ovarian carcinoma

MiRNA-200b as a prognostic factor in invasive duct carcinoma Nivin A. Hassan 1, Tarek M. Elsaba 2, Samia A. Shouman 3

MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells

Analysis of serum exosomal micrornas and clinicopathologic features of patients with pancreatic adenocarcinoma

MiR-155 promotes the proliferation and migration of breast cancer cells via targeting SOCS1 and MMP16

MicroRNAs: the primary cause or a determinant of progression in leukemia?

MicroRNA expression profiling and functional analysis in prostate cancer. Marco Folini s.c. Ricerca Traslazionale DOSL

Regulation of the transcription factor NF-kappaB1 by microrna-9 in human gastric adenocarcinoma

Regulation of the transcription factor NF- B1 by microrna-9 in human gastric adenocarcinoma

Computational Approaches for Identifying Cancer mirna Expressions

Original Article MicroRNA-592 targets DEK oncogene and suppresses cell growth in the hepatocellular carcinoma cell line HepG2

MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers

Original Article MiR-29a-3p suppresses the proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting IGF-1

micrornas as oncogenes and tumor suppressors

mir-129b suppresses cell proliferation in the human lung cancer cell lines A549 and H1299

MicroRNAs (mirnas) are highly conserved small

mir-182 as a Prognostic Marker for Glioma Progression and Patient Survival

Original Article Downregulation of microrna-504 is associated with poor prognosis in high-grade glioma

microrna-99a acts as a tumor suppressor and is down-regulated in bladder cancer

Original Article MicroRNA Expression Profiling Outperforms mrna Expression Profiling in Formalin-fixed Paraffin-embedded Tissues

Review. microrna, Cell Cycle, and Human Breast Cancer

Int J Clin Exp Med 2017;10(10): /ISSN: /IJCEM

Overexpression of mirna-21 promotes radiation-resistance of non-small cell lung cancer

MicroRNA-92gene expression in epithelial ovarian cancer using a novel Real-Time Polymerase change reaction

MicroRNA Signature Predicts Survival and Relapse in Lung Cancer

Effect of Onconase on Double-stranded RNA In Vitro

Down Regulated Micro RNA-145 as a Marker to Diagnose Breast Cancer in Egypt

micrornas as tumor inhibitors, oncogenes, biomarkers for drug efficacy and outcome predictors in lung cancer (Review)

MicroRNA genes are frequently located near mouse cancer susceptibility loci.

Received: 23 June 2006 Accepted: 19 July 2006

Clinical significance of serum mir-21 in breast cancer compared with CA153 and CEA

Expression Analysis of mir-21 and mir-221 in Cancerous Tissues from Iranian Patients with Gastric Cancer

Original Article MiR-23b inhibits cell migration and invasion through targeting PDE7A in colon cancer cells

Evidence for dietary regulation of microrna expression in cancer cells

Genetic variation of mirna sequence in pancreatic cancer

Profiles of gene expression & diagnosis/prognosis of cancer. MCs in Advanced Genetics Ainoa Planas Riverola

The detection of differentially expressed micrornas from the serum of ovarian cancer patients using a novel real-time PCR platform

Supplemental Table 1. MicroRNAs (mirnas) up- or downregulated in various

Original Article Serum expression of mirna-103, a potential diagnostic and prognostic biomarker for colorectal cancer

Identification of a MicroRNA Panel for Clear-cell Kidney Cancer

MiR-146a polymorphism correlates with lung cancer risk in Chinese nonsmoking females

Development of the human cancer microrna network

Original Article Up-regulation of mir-10a and down-regulation of mir-148b serve as potential prognostic biomarkers for osteosarcoma

Evaluation of altered expression of mir-9 and mir-106a as an early diagnostic approach in gastric cancer

Up-regulation of microrna-375 inhibits the proliferation of gastric cancer cell through targeting AEG-1.

developing new tools for diagnostics Join forces with IMGM Laboratories to make your mirna project a success

The mir-15a-mir-16-1 Locus is Homozygously Deleted in a Subset of Prostate Cancers

Progress risk assessment of oral premalignant lesions with saliva mirna analysis

MicroRNA expression after ionizing radiation in human endothelial cells

BMC Cancer. Open Access. Abstract. BioMed Central

CDKN2A, NF2, and JUN Are Dysregulated Among Other Genes by mirnas in Malignant Mesothelioma A mirna Microarray Analysis

Preliminary data on microrna expression profiles in a group of South African patients diagnosed with chronic myeloid leukaemia

Identification of new mirna biomarkers associated with HER2-positive breast cancers

An Investigation of the Effect of Hypoxia on Expression of 107-miR in Gastric Cancer Cell Lines MKN-45 and AGS

MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia

Genome-wide microrna profiling in human fetal nervous tissues by oligonucleotide microarray

Profiles of gene expression & diagnosis/prognosis of cancer Lorena Roa de la Cruz

Mir-595 is a significant indicator of poor patient prognosis in epithelial ovarian cancer

microrna Presented for: Presented by: Date:

Identification of six key mirnas associated with breast cancer through screening large scale microarray data

Inhibition of the Growth of Raji Cells by Precursor MicroRNA-15a

Downregulation of serum mir-17 and mir-106b levels in gastric cancer and benign gastric diseases

Original Article MicroRNA-129-3p functions as a tumor suppressor in serous ovarian cancer by targeting BZW1

Original Article Serum microrna-34c acts as a novel diagnostic biomarker in breast cancer patients

Dysregulation of MicroRNAs in cancer

Up-regulation of serum mir-4262 predicts clinical outcome of patients with acute myeloid leukemia

micrornas (mirna) and Biomarkers

MiR-99a may serve as a potential oncogene in pediatric myeloid leukemia

The lymphoma-associated NPM-ALK oncogene elicits a p16ink4a/prb-dependent tumor-suppressive pathway. Blood Jun 16;117(24):

DESIGN OF A DUAL PLASMID SYSTEM FOR OVER- EXPRESSING MICRORNAS RELATED TO BREAST CANCER

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

Original Article Diagnostic value of circulating mir-155, mir-21, and mir-10b as promising biomarkers in human breast cancer

MicroRNAs as biomarkers in leukemia

Association of mir-21 with esophageal cancer prognosis: a meta-analysis

Detection of let-7a MicroRNA by Real-time PCR in Colorectal Cancer: a Single-centre Experience from China

MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer

MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN

Using Data from the Cancer Genome Atlas to Investigate Molecular Events Related to Ovarian Cancer. Abstract

Secrum microrna-122 with HCC in chronic hepatitis C

MiR-539-3p promotes the progression of epithelial ovarian cancer by targeting SPARCL1

Role of MicroRNA in Breast Cancer

MiR-203 Determines Poor Outcome and Suppresses Tumor Growth by Targeting TBK1 in Osteosarcoma

The mir cluster as a potential biomarker for the early diagnosis of gastric cancer: evidence and literature review

MicroRNAs in Head and Neck Squamous Cell Carcinoma (HNSCC) and Oral Squamous Cell Carcinoma (OSCC)

Low levels of serum mir-99a is a predictor of poor prognosis in breast cancer

Evaluating the Consistency of Differential Expression of MicroRNA Detected in Human Cancers

Combined transfection of Bcl-2 sirna and mir-15a oligonucleotides enhanced methotrexate-induced apoptosis in Raji cells

Oncogenic MicroRNAs: mir-155, mir-19a, mir-181b, and mir-24 enable monitoring of early breast cancer in serum

The adult heart is a dynamic organ capable of significant

14: Alder H, Taccioli C, Chen H, Jiang Y, Smalley KJ, Fadda P, Ozer HG, Huebner

Oncogenic MicroRNAs: mir-155, mir-19a, mir-181b, and mir-24 enable monitoring of early breast cancer in serum

Decreased expression of key tumour suppressor micrornas is associated with lymph node metastases in triple negative breast cancer

MicroRNAs, Cellular Behavior, and Endometrial Cancer

Corrections PNAS February 14, 2006 vol. 103 no cgi doi pnas

Plasma specific mirnas as predictive biomarkers for diagnosis and prognosis of glioma

CONTRACTING ORGANIZATION: Rutgers University Piscataway, NJ

NIH Public Access Author Manuscript Int J Cancer. Author manuscript; available in PMC 2013 January 15.

Transcription:

MicroRNA Cancer qpcr Array Array Layout Pre-designed set of 95 MicroRNA detection Primers U6 snrna Normalization transcript

Selection of Candidate MicroRNAs for Cancer Array Sample References of MicroRNA and Cancer Literature Survey Breast Cancer: MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005 Aug 15;65(16):7065-70. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. MicroRNA expression profiles classify human cancers Nature. 2005 Jun 9;435(7043):745-6. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. B-cell Leukemia: MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11755-60. Epub 2004 Jul 29. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD, Shimizu M, Cimmino A, Zupo S, Dono M, Dell'Aquila ML, Alder H, Rassenti L, Kipps TJ, Bullrich F, Negrini M, Croce CM. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med. 2005 Oct 27;353(17):1793-801. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM. Lung Cancer: Unique microrna molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006 Mar;9(3):189-98. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC. Related A polycistronic microrna cluster, mir-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 2005 Nov 1;65(21):9628-32. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y, Takahashi T. MicroRNA and lung cancer N Engl J Med. 2005 Jun 9;352(23):2446-8. Eder M, Scherr M. Pancreatic Cancer: Expression profiling identifies microrna signature in pancreatic cancer. Int J Cancer. 2006 Dec 5; [Epub ahead of print] Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL, Morgan DL, Postier RG, Brackett DJ, Schmittgen TD. Solid Tumors: A microrna expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61. Epub 2006 Feb 3. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. MicroRNA and Cancer Reviews/Other Publications: Cancer genomics: small RNAs with big impacts. Nature. 2005 Jun 9;435(7043):745-6. Meltzer, PS. MicroRNAs in Gene Regulation: When the Smallest Governs It All. J Biomed Biotechnol. 2006;2006(4):69616. Ouellet DL, Perron MP, Gobeil LA, Plante P, Provost P. MicroRNAs as oncogenes. Curr Opin Genet Dev. 2006 Feb;16(1):4-9. Epub 2005 Dec 19. Hammond SM. Oncomirs - micrornas with a role in cancer. Nat Rev Cancer. 2006 Apr;6(4):259-69. Esquela-Kerscher A, Slack FJ. micrornas as oncogenes and tumor suppressors. Dev Biol. 2006 Aug 16; [Epub ahead of print] Zhang B, Pan X, Cobb GP, Anderson TA. MicroRNAs and the hallmarks of cancer. Oncogene. 2006 Oct 9;25(46):6170-5. Dalmay T, Edwards DR micrornas exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9136-41. Epub 2006 Jun 5. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR, Yao G, Medina A, O'brien-Jenkins A, Katsaros D, Hatzigeorgiou A, Gimotty PA, Weber BL, Coukos G.

End-point PCR MicroRNA Primer Validation Pool of 18 Normal and 7 Tumor RNAs used as starting template (5µg total). Anneal temp 60ºC, 31 cycles with 3.5% agarose gel electrophoresis.

Sensitive and Quantitative Real-time Data Ct average = 18.33 Ct range = 13.02 25.49 * Sensitive down to 200 pg starting RNA Ideal for: Biopsies LCM Rare samples Dynamic Range > 5000 fold

Cancer qpcr Array Workflow

Collaborator Cancer Array Data 1000.0000 Normalized Tumor MicroRNA levels 100.0000 10.0000 Fold Change 1.0000 0.1000 0.0100 0.0010 0.0001 Cancer Biomarker Discovery

Cancer qpcr Array Kit Contents Complete Reagent Kit to prepare microrna cdna and enough Primers to perform 10 entire qpcr Array measurements (960 reactions) Plus U6 control

System Biosciences (SBI) 1616 North Shoreline Blvd. Mountain View, CA 94043 ORDERING INFORMATION: Phone: 650-968-2200 Toll-Free: 888-266-5066 Fax: 650-968-2277 info@systembio.com www.systembio.com